Dinamo Biotechnologies
- Diagnostics
- Other R&D services
- Synthesis, analytic, diagnostic services
- Biotech or pharma, therapeutic R&D
Liquid Biopsy for Immunology. Dinamo provides blood-based cfDNA biomarker solutions designed specifically for Immunology indications.
Dinamo helps de-risk Immunology development programs by providing patient stratification and molecular response monitoring biomarker solutions. We deliver mechanistic biological insights to aid new target identification or label expansion efforts.
Dinamo brings together the latest advancements in cfDNA analysis in liquid biopsy format – non-invasive to patients, with minimal sample volume requirements. Our AI/ML-driven analytics resolve complex molecular signatures to address key challenges in immunology drug development.
Specialized in Immunology, Dinamo has the focus and agility to partner with Immunology drug developers for precision medicine biomarker development tailored to specific indications and development stages.
We are excited to partner with Pharma and Biotech companies to bring the power of Liquid Biopsy to Immunology.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}